Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Myriad Genetics Inc (NASDAQ:MYGN)

38.82
Delayed Data
As of Sep 02
 +2.17 / +5.92%
Today’s Change
30.30
Today|||52-Week Range
39.95
+13.98%
Year-to-Date

Today’s Trading

Previous close36.65
Today’s open37.41
Day’s range37.08 - 39.00
Volume1,443,887
Average volume (3 months)782,489
Market cap$2.5B
Dividend yield--
Data as of 09/02/2015

Growth & Valuation

Earnings growth (last year)-52.00%
Earnings growth (this year)+13.37%
Earnings growth (next 5 years)+7.58%
Revenue growth (last year)-7.08%
P/E ratio36.1
Price/Sales3.50
Price/Book3.81

Competitors

 Today’s
change
Today’s
% change
CXRXConcordia Healthcare...+2.60+3.36%
CBPOChina Biologic Produ...+3.08+3.29%
INSYINSYS Therapeutics I...+1.62+4.97%
MDCOMedicines Co+0.67+1.64%
Data as of 3:59pm ET, 09/02/2015

Financials

Next reporting dateNovember 3, 2015
EPS forecast (this quarter)$0.35
Annual revenue (last year)$723.1M
Annual profit (last year)$80.2M
Net profit margin11.09%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Mark C. Capone
Executive Vice President-
International Operations
Gary A. King
Corporate headquarters
Salt Lake City, Utah

Forecasts

Partner Offers